Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Renner

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Journal of Viral Hepatitis|October 21, 2006
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirinBeat Helbling, Wolfram Jochum, Ivan Stamenic, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|May 27, 2005
Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patientsM M Nascimento, A Bruchfeld, M E Suliman, et al.
Gut|July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infectionB Helbling, K Overbeck, J-J Gonvers, et al.
Journal of Viral Hepatitis|June 24, 2006
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosisB Meyer-Wyss, P Rich, Hp Egger, et al.
Infection|February 14, 2007
F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapyK D M Stumpe, E C Renner-Schneiter, A K Kuenzle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2016
Donor BMI >30 Is Not a Contraindication for Live Liver DonationM Knaak, N Goldaracena, A Doyle, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantationMarkus Selzner, Arash Kashfi, Nazia Selzner, et al.
Critical Care (London, England)|February 12, 2013
Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort studyConstantine J Karvellas, Thomas Lescot, Peter Goldberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2015
Live donor liver transplantation: a valid alternative for critically ill patients suffering from acute liver failureN Goldaracena, V N Spetzler, M Marquez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2009
A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantationMarkus Selzner, Arash Kashfi, Mark S Cattral, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Journal of Viral Hepatitis|October 21, 2006
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirinBeat Helbling, Wolfram Jochum, Ivan Stamenic, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|May 27, 2005
Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patientsM M Nascimento, A Bruchfeld, M E Suliman, et al.
Gut|July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infectionB Helbling, K Overbeck, J-J Gonvers, et al.
Journal of Viral Hepatitis|June 24, 2006
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosisB Meyer-Wyss, P Rich, Hp Egger, et al.
Infection|February 14, 2007
F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapyK D M Stumpe, E C Renner-Schneiter, A K Kuenzle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2016
Donor BMI >30 Is Not a Contraindication for Live Liver DonationM Knaak, N Goldaracena, A Doyle, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantationMarkus Selzner, Arash Kashfi, Nazia Selzner, et al.
Critical Care (London, England)|February 12, 2013
Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort studyConstantine J Karvellas, Thomas Lescot, Peter Goldberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2015
Live donor liver transplantation: a valid alternative for critically ill patients suffering from acute liver failureN Goldaracena, V N Spetzler, M Marquez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2009
A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantationMarkus Selzner, Arash Kashfi, Mark S Cattral, et al.
Pageof 18